Clinical Trials Browser

Recruiting × Dendritic Cell Sarcoma, Interdigitating × 90 days × Clear all

Dendritic Cell Sarcoma, Interdigitating

NCT07249905 2026-05-04

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Dendritic Cell Sarcoma, Interdigitating

NCT07548697 2026-04-23

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

Phase EARLY_PHASE1 Recruiting

24 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Lymphoma, B-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT06544265 2026-04-14

SynKIR-310 for Relapsed/Refractory B-NHL

Phase 1 Recruiting

36 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Pyloric Stenosis, Hypertrophic, Dendritic Cell Sarcoma, Interdigitating

NCT06481826 2026-03-27

Glofitamab in Chinese Patients With R/R DLBCL

Recruiting

20 enrolled

Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

CAR-T Followed by Bispecific Antibodies

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

SynKIR-310 for Relapsed/Refractory B-NHL

Glofitamab in Chinese Patients With R/R DLBCL